Skip to main content
EJNMMI Research
Fig. 5 | EJNMMI Research

Fig. 5

From: Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor

Fig. 5

Clustering (%) represents the degree of voxel clustering for all lesions, for the three time points: baseline, 7 days post-therapy and 28 days post-therapy. Voxels are more clustered when the percentage is closer to 100%. *TBF data for patient 5 was unavailable and therefore the clustering parameter could not be determined 7 days after treatment

Back to article page